公开(公告)号：US20240115528A1

公开(公告)日：2024-04-11

申请号：US18262942

申请日：2022-01-26

Applicant: KAO CORPORATION

Inventor： Takashi UCHIDA ,  Makoto NOHARA ,  Emi OKUBO ,  Shinzo OSUMI ,  Ryosuke FUJII

IPC: A61K31/192 ,  A61K9/12 ,  A61K9/70 ,  A61K31/045 ,  A61K31/165 ,  A61K31/618 ,  A61K36/534 ,  A61K47/06 ,  A61K47/10 ,  A61K47/14 ,  A61K47/18 ,  A61K47/32 ,  A61K47/38

CPC classification number: A61K31/192 ,  A61K9/12 ,  A61K9/7015 ,  A61K31/045 ,  A61K31/165 ,  A61K31/618 ,  A61K36/534 ,  A61K47/06 ,  A61K47/10 ,  A61K47/14 ,  A61K47/18 ,  A61K47/32 ,  A61K47/38

Abstract: A composition, including (A) a medicinal ingredient, (B) a water-insoluble polymer, (C) a non-volatile base, (D) a volatile solvent, and (E) water. The composition has a viscosity at 25° C. of 1.0 mPa·s or more and 10,000 mPa·s or less. The component (A) contains one or more selected from the group consisting of an anti-inflammatory analgesic component, a local irritation component, a blood circulation promoting component, an antihistamine component, a crude drug component, an antipruritic component, a local anesthetic component, a keratin softening component, and an antibacterial component. A mass ratio [(C)/(B)] of the component (C) to the component (B) in the composition is 0.05 or more and 10 or less, and a mass ratio [(E)/(D)] of the component (E) to the component (D) in the composition is 0.005 or more and 1.0 or less.